[an error occurred while processing this directive]
Gene set: IFNA_HCC_TOLERANT_UP (C2:PERT:0134)
Standard nameIFNA_HCC_TOLERANT_UP
Systematic nameC2:PERT:0134
Brief descriptionGenes highly expressed in interferon-resistant hepatoma cell lines (HKCI-C1-3) vs. sensitive cell lines (HKCI-1-4,HepG2,Hep3B,PCL/PRF/5)
CategoryC2: Curated
Sub-categoryPERT: Experimental pertuberation
Full description or Abstract

Toggle abstract view

PURPOSE: Treatment with IFN-alpha therapy has been shown to exhibit
antitumor effects on patients with hepatocellular carcinoma (HCC).
However, individual responses remained unpredictable because of
the frequent presence of intrinsic or acquired IFN-alpha resistance.
Hence, delineation of molecular targets implicated in the resistant
pathway holds value in refining the therapeutic benefits of IFN-alpha.
EXPERIMENTAL DESIGN: The current study analyzed the effect of
IFN-alpha in human HCC cells. Three hepatitis C virus (HCV)-related,
five hepatitis B virus (HBV)-related and two non-B non-C-related
cell lines were subjected to IFN-alpha treatment and the cytotoxic
effect on cell viability was measured. Further analysis by cDNA
microarray and quantitative reverse transcription-PCR were conducted
to examine the gene expression changes that mediated the IFN-alpha
resistance observed. RESULTS: According to the IC(50) values determined,
HCV-related cell lines indicated distinct resistance (IC(50),
389-1468 units/mL) compared with the HBV-related (IC(50), 11-77
units/mL) and non-B non-C-related cell lines (IC(50), 24-108 units/mL).
Unsupervised hierarchical clustering on array data indicated three
HCV-related cell lines to cluster independently from the sensitive
cell lines, suggesting discrete features in association with IFN-alpha
tolerance. Moreover, Significance Analysis of Microarrays analysis
indicated the differential expression of 149 expressed sequence
tags that represented 51 up-regulated and 98 down-regulated genes
in the resistant cell lines. Comparing the temporal pattern of
gene expression between 6- and 24-hour treatments, candidate genes
that were considerably induced with time were further highlighted
in the tolerant HCV-related cell lines. These candidates were
verified by quantitative reverse transcription-PCR, which confirmed
the down-regulation of UBA2, ZNF185, and FOXF1 and up-regulation
of UBE4B in the drug-tolerant cells. CONCLUSIONS: Our present
study showed that the insensitivity to IFN-alpha therapy in HCC
cells is associated with drug-inducible transcriptional alterations.
Furthermore, our investigation highlighted potential candidate
genes in conferring an anti-apoptotic effect toward IFN-alpha
treatment. 
Publication URL15709204
External linksna
Keywords & MeSH headingsOligonucleotide Array Sequence Analysis/methods,Gene Expression Profiling,Cell Survival/drug effects,pharmacology,Transcription,Drug,Humans,Tumor Necrosis Factor-alpha,Dose-Response Relationship,Hepatitis C/pathology/virology,Genetic/genetics,genetics,Gene Expression Regulation,Neoplastic/drug effects,Neoplasm,Liver Neoplasms/genetics/pathology/virology,Cell Division/drug effects,Drug Resistance,Cluster Analysis
OrganismHuman
Contributed byYujin Hoshida
Source platformGene_Symbol
Downloadgrp|xml|map
Genes

18 genes, 18 accessions (Toggle view)

GeneTitleLinks
TNRC5trinucleotide repeat containing 5Source|GeneCards
BIRC3baculoviral IAP repeat-containing 3Source|GeneCards
AKT2v-akt murine thymoma viral oncogene homolog 2Source|GeneCards
REV3LREV3-like, catalytic subunit of DNA polymerase zeta (yeast)Source|GeneCards
CDC42cell division cycle 42 (GTP binding protein, 25kDa)Source|GeneCards
SNX1sorting nexin 1Source|GeneCards
GTF2F1general transcription factor IIF, polypeptide 1, 74kDaSource|GeneCards
IFITM1interferon induced transmembrane protein 1 (9-27)Source|GeneCards
EPHB6EphB6Source|GeneCards
DHX34DEAH (Asp-Glu-Ala-His) box polypeptide 34Source|GeneCards
UBE4Bubiquitination factor E4B (UFD2 homolog, yeast)Source|GeneCards
IDSiduronate 2-sulfatase (Hunter syndrome)Source|GeneCards
SLC5A2solute carrier family 5 (sodium/glucose cotransporter), member 2Source|GeneCards
BAI2brain-specific angiogenesis inhibitor 2Source|GeneCards
GDAP1L1ganglioside-induced differentiation-associated protein 1-like 1Source|GeneCards
TLL1tolloid-like 1Source|GeneCards


[an error occurred while processing this directive]